首页> 美国卫生研究院文献>Springer Open Choice >Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies

【2h】

Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies

机译：在中度至重度斑块状牛皮癣患者中使用Guselkumab改善患者报告的结果（皮肤病生活质量指数和牛皮癣症状和体征日记）：III期VOYAGE 1和VOYAGE 2研究的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BackgroundHealth-related quality of life (HRQoL) may be markedly impaired in patients with moderate-to-severe psoriasis.

机译：背景：中重度牛皮癣患者的健康相关生活质量（HRQoL）可能明显受损。

著录项

期刊名称 Springer Open Choice
作者
April W. Armstrong; Kristian Reich; Peter Foley; Chenglong Han; Michael Song; Yaung-Kaung Shen; Yin You; Kim A. Papp;
展开▼
作者单位

展开▼
年(卷),期 -1(20),1
年度 -1
页码 155–164
总页数 10
原文格式 PDF
正文语种
中图分类外科学;
关键词

相似文献

外文文献
中文文献

1. Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies [J] . Armstrong April W., Reich Kristian, Foley Peter, American journal of clinical dermatology . 2019,第1期

机译：患者报告的结果（皮肤科生活质量指数和牛皮癣症状和签署日志）的改善在中度至重度斑块牛皮癣中：III期Voyage 1和Voyage 2研究的结果
2. Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studies [J] . Gordon K. B., Blauvelt A., Foley P., British Journal of Dermatology . 2018,第1期

机译：Guselkumab在中度至重度斑块牛皮癣患者群中的疗效：III期Voyage 1和Voyage 2研究的合并分析
3. Safety in moderate-to-severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti-tuberculosis treatments concomitantly: results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trials [J] . Puig L., Tsai T. -F., Bhutani T., Journal of the European Academy of Dermatology and Venereology: JEADV . 2020,第8期

机译：中度至重度斑块牛皮癣的安全性伴有Guselkumab和抗结核治疗治疗的潜在结核病患者：汇总阶段3 Voyage 1和Voyage 2试验的结果
4. The impact of pruritus on the health-related quality of life of patients with chronic plaque psoriasis [D] . Majeski, Candace Julie Ann 2006

机译：瘙痒对慢性斑块牛皮癣患者健康有关质量的影响
5. Patient‐reported symptoms and signs of moderate‐to‐severe psoriasis treated with guselkumab or adalimumab: results from the randomized VOYAGE 1 trial [O] . K.A. Papp, A. Blauvelt, A.B. Kimball, -1

机译：用古塞珠单抗或阿达木单抗治疗的患者报告的症状至中重度银屑病：VOYAGE 1随机试验结果
6. Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies [O] . April W. Armstrong, Kristian Reich, Peter Foley, 2018

机译：患者报告的结果（皮肤科生活质量指数和牛皮癣症状和签署日记）的改善在中度至严重的斑块牛皮癣中：III期Voyage 1和Voyage 2研究的结果

Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅